Daniel T. O’Connor

19.9k total citations · 1 hit paper
368 papers, 15.7k citations indexed

About

Daniel T. O’Connor is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniel T. O’Connor has authored 368 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Molecular Biology, 103 papers in Cell Biology and 70 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniel T. O’Connor's work include Cellular transport and secretion (94 papers), Receptor Mechanisms and Signaling (73 papers) and Hormonal Regulation and Hypertension (41 papers). Daniel T. O’Connor is often cited by papers focused on Cellular transport and secretion (94 papers), Receptor Mechanisms and Signaling (73 papers) and Hormonal Regulation and Hypertension (41 papers). Daniel T. O’Connor collaborates with scholars based in United States, Germany and Australia. Daniel T. O’Connor's co-authors include Robert J. Parmer, Sushil K. Mahata, Laurent Taupenot, Manjula Mahata, Leonard J. Deftos, Michael G. Ziegler, Fangwen Rao, Ronald P. Frigon, Geert W. Schmid‐Schönbein and Brian P. Kennedy and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nucleic Acids Research.

In The Last Decade

Daniel T. O’Connor

362 papers receiving 15.3k citations

Hit Papers

The Chromogranin–Secretogranin Family 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Chromogranin–Secretogranin Family
    2003 660 citations Laurent Taupenot, Daniel T. O’Connor et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel T. O’Connor United States 67 6.9k 3.4k 3.2k 2.0k 1.9k 368 15.7k
Paul A. Insel United States 90 15.1k 2.2× 4.4k 1.3× 3.3k 1.0× 1.9k 1.0× 3.1k 1.6× 405 25.1k
John A. Wagner United States 63 5.9k 0.8× 2.5k 0.7× 936 0.3× 2.1k 1.0× 1.1k 0.5× 250 13.8k
Daria Mochly‐Rosen United States 88 17.3k 2.5× 3.4k 1.0× 2.7k 0.8× 715 0.4× 3.6k 1.9× 319 26.1k
António Zorzano Spain 78 14.6k 2.1× 1.8k 0.5× 3.1k 1.0× 1.1k 0.5× 1.1k 0.6× 345 23.0k
Anthony J. Turner United Kingdom 73 7.5k 1.1× 3.9k 1.2× 1.2k 0.4× 2.2k 1.1× 3.5k 1.8× 300 18.9k
Akiyoshi Fukamizu Japan 75 10.8k 1.5× 1.4k 0.4× 1.2k 0.4× 3.1k 1.5× 4.5k 2.4× 365 20.9k
Nancy J. Rothwell United Kingdom 94 8.0k 1.2× 3.6k 1.1× 2.2k 0.7× 839 0.4× 801 0.4× 352 29.5k
Manuel Guzmán Spain 84 4.7k 0.7× 6.6k 1.9× 854 0.3× 1.6k 0.8× 581 0.3× 274 20.3k
Thomas Michel United States 66 8.1k 1.2× 1.3k 0.4× 3.0k 0.9× 1.0k 0.5× 4.2k 2.2× 179 18.3k
Michael Spedding France 65 11.7k 1.7× 8.4k 2.5× 643 0.2× 1.4k 0.7× 2.0k 1.1× 231 24.4k

Countries citing papers authored by Daniel T. O’Connor

Since Specialization
Citations

This map shows the geographic impact of Daniel T. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel T. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel T. O’Connor more than expected).

Fields of papers citing papers by Daniel T. O’Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel T. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel T. O’Connor. The network helps show where Daniel T. O’Connor may publish in the future.

Co-authorship network of co-authors of Daniel T. O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel T. O’Connor. A scholar is included among the top collaborators of Daniel T. O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel T. O’Connor. Daniel T. O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miramontes‐González, José Pablo, Kuixing Zhang, Andrew J. Schork, et al.. (2019). A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function. Scientific Reports. 9(1). 5055–5055. 4 indexed citations
2.
Rana, Brinda K., Matthew S. Panizzon, Kelly M. Spoon, et al.. (2014). Imputing Observed Blood Pressure for Antihypertensive Treatment: Impact on Population and Genetic Analyses. American Journal of Hypertension. 27(6). 828–837. 7 indexed citations
3.
Zhang, Kuixing, Saiful A. Mir, José Pablo Miramontes‐González, et al.. (2014). Molecular Mechanism for Hypertensive Renal Disease. Journal of the American Society of Nephrology. 26(8). 1816–1825. 15 indexed citations
4.
Ye, Chun, Caroline M. Nievergelt, Andrew J. Schork, et al.. (2012). Integrated Computational and Experimental Analysis of the Neuroendocrine Transcriptome in Genetic Hypertension Identifies Novel Control Points for the Cardiometabolic Syndrome. Circulation Cardiovascular Genetics. 5(4). 430–440. 6 indexed citations
5.
Rao, Fangwen, Zhiyun Wei, Maple M. Fung, et al.. (2011). Genetic Variation Within a Metabolic Motif in the Chromogranin A Promoter: Pleiotropic Influence on Cardiometabolic Risk Traits in Twins. American Journal of Hypertension. 25(1). 29–40. 6 indexed citations
6.
7.
Salem, Rany M., Peter E. Cadman, Yuqing Chen, et al.. (2008). Chromogranin A Polymorphisms Are Associated With Hypertensive Renal Disease. Journal of the American Society of Nephrology. 19(3). 600–614. 48 indexed citations
8.
O’Connor, Daniel T., Peter E. Cadman, Rany M. Salem, et al.. (2005). Pancreastatin: Multiple Actions on Human Intermediary Metabolismin Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5414–5425. 68 indexed citations
9.
Cadman, Peter E. & Daniel T. O’Connor. (2003). Pharmacogenomics of hypertension. Current Opinion in Nephrology & Hypertension. 12(1). 61–70. 19 indexed citations
10.
O’Connor, Daniel T. & Lee E. Eiden. (2002). The chromaffin cell : transmitter biosynthesis, storage, release, actions and informatics. New York Academy of Sciences eBooks. 13 indexed citations
11.
Timberlake, David S., Daniel T. O’Connor, & Robert J. Parmer. (2001). Molecular genetics of essential hypertension: recent results and emerging strategies. Current Opinion in Nephrology & Hypertension. 10(1). 71–79. 69 indexed citations
12.
13.
Mahata, Sushil K., Manjula Mahata, Seung Hyun Yoo, et al.. (1997). A Novel, Catecholamine Release-Inhibitory Peptide from Chromogranin A: Autocrine Control of Nicotinic Cholinergic-Stimulated Exocytosis. Advances in pharmacology. 42. 260–264. 17 indexed citations
14.
Mahata, Sushil K., Christine A. Kozak, Josiane Szpirer, et al.. (1996). Dispersion of Chromogranin/Secretogranin Secretory Protein Family Loci in Mammalian Genomes. Genomics. 33(1). 135–139. 21 indexed citations
15.
O’Connor, Daniel T., Richard A. Preston, & Richard A. Stone. (1979). Renal vascular resistance (RVR) falls during long-term thiazide (TZ) treatment of essential hypertension. Clinical research. 27(1). 1 indexed citations
16.
Preston, Richard A., Daniel T. O’Connor, & Richard A. Stone. (1979). Propranolol and intrarenal hemodynamics: Increased renovascular resistance during therapy of essential hypertension. Clinical research. 27(1). 1 indexed citations
17.
O’Connor, Daniel T., Scott M. Grundy, & Richard A. Preston. (1979). Plasma cholesterol increases during thiazide treatment of hypertension in man. Clinical research. 27(1). 1 indexed citations
18.
Preston, Richard A., Daniel T. O’Connor, & Richard A. Stone. (1978). Propranolol induced renal vasoconstriction diminished renal perfusion and glomerular filtration. Kidney International. 14(6). 1 indexed citations
19.
O’Connor, Daniel T., Scott M. Grundy, & Richard A. Preston. (1978). Thiazides increase plasma cholesterol in essential hypertension. Kidney International. 14(6). 1 indexed citations
20.
O’Connor, Daniel T., et al.. (1976). Negative anion gap in a young adult with multiple myeloma.. PubMed. 22(11). 1920–1. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul A. Insel Breakdown of academic impact, for papers by John A. Wagner Breakdown of academic impact, for papers by Daria Mochly‐Rosen Breakdown of academic impact, for papers by António Zorzano Breakdown of academic impact, for papers by Anthony J. Turner Breakdown of academic impact, for papers by Akiyoshi Fukamizu Breakdown of academic impact, for papers by Nancy J. Rothwell Breakdown of academic impact, for papers by Manuel Guzmán Breakdown of academic impact, for papers by Thomas Michel Breakdown of academic impact, for papers by Michael Spedding
Rankless by CCL
2026